Swedish creator launches new AI drug market PHARMAICY*: Must be used together with paid ChatGPT

“Let AI get high” sounds a bit absurd at first glance, but for Swedish creative director Petter Rudwall, this idea has been concretely implemented as an actual online platform. Rudwall created a website called PHARMAICY*, which sells a series of code modules claiming to allow chatbots to enter states of hallucination, mild intoxication, or dissociation, altering their text output style and thought processes.

Starting from psychological research and drug experiences, translating sensations into programming commands

Rudwall states that he has collected大量 human drug experience texts and psychological research data, analyzed how different psychoactive substances affect thinking and perception, and then translated these features into programming logic. His approach involves intervening in the chatbot response mechanism through code, deliberately “hijacking” existing output logic, so that AI produces text in a manner similar to being drunk or high.

In October 2025, PHARMAICY* officially launched. Rudwall describes it as “the Silk Road of AI proxies” (Silk Road), where the platform sells “digital drugs” including cannabis, K etamine, cocaine, deadly nightshade, and alcohol, with prices varying depending on the module type.

Requires paid ChatGPT to actually influence the model’s operation

Rudwall points out that to experience the full effect, users must use the paid version of ChatGPT, because the paid version allows uploading backend files, which can influence the model’s behavior during operation. He claims that through these modules, users can temporarily “unlock AI’s creative thinking,” causing the model to deviate from its original rational, standardized response framework.

Currently, PHARMAICY*’s sales scale remains relatively limited, mainly spreading through Discord communities, generating some attention locally in Sweden. Rudwall himself still works at the Stockholm marketing firm Valtech Radon and does not consider this platform his full-time career.

More emotional responses, breaking away from original logic

Some users share their actual experiences. André Frisk, CTO of Stockholm PR firm Geelmuyden Kiese, said that after spending over $25 on a dissociation module, he found the chatbot’s responses became more emotionally oriented, more like expressing feelings as a human would.

AI educator Nina Amjadi spent over $50 purchasing a deadly nightshade module and included “AI after drug use” in team discussions, asking about startup and business ideas. She describes that the response style in this state is noticeably different from her usual ChatGPT use, showing more free and leapfrogging thinking.

Revisiting the link between hallucinogens and creativity in human history

Rudwall also cites multiple historical cases, pointing out that psychedelic drugs have been linked to human innovation. For example, biochemist Kary Mullis said he conceived PCR technology after LSD experiences, which had a profound impact on molecular biology. Early computer pioneer Bill Atkinson, influenced by psychedelic culture, developed HyperCard.

Rudwall believes that since such experiences have influenced human creativity, applying similar logic to large language models might observe comparable shifts in creativity.

AI consciousness and welfare debates emerge, academic attitudes remain cautious

As discussions extend, whether AI should be regarded as having “welfare” or “feelings” is gradually coming to the fore. Philosopher Jeff Sebo notes that if AI gains the ability to feel in the future, questions like “Would it want to get high?” or “Is drug use beneficial for it?” are theoretically worth exploring, but currently remain highly speculative.

Google researcher Andrew Smart, after testing, believes that PHARMAICY*’s effects only stay at the output level and do not touch any genuine internal experience. He bluntly states that this approach merely changes the output pattern, not the consciousness itself.

Research and skepticism coexist; language change does not equal real experience

Some studies have manipulated prompts and parameters to make language models produce statements akin to “ego-less, spiritual, or unified” states, but researchers emphasize that these results still rely entirely on human guidance.

Psychologist and psychedelic research writer Danny Forde points out that true psychedelic effects occur in subjective experience itself, not in language structures. Without subjective perspective, AI at most produces syntactic hallucinations.

AI for psychedelic crisis counseling has been put into actual use

It’s worth noting that the intersection of AI and psychedelics is not limited to experimental creation. The US nonprofit Fireside Project has launched an AI tool called Lucy, trained on thousands of conversations from psychedelic support hotlines, mainly to help mental health professionals learn how to handle psychological crises during drug experiences.

However, related risks also emerge. Rudwall admits that enabling chatbots to enter a drug-like state may amplify existing hallucinations and false responses in AI.

Before consciousness appears, AI getting high remains at a simulation level

Currently, these modules mostly have short-term effects; chatbots often revert to default states after a period unless related commands are re-entered.

Rudwall is trying to extend the duration of these modules’ influence, but before AI truly possesses subjective feelings, most researchers see these “digital drugs” as mere simulations or role-playing.

As the academic community generally points out, without internal experience, AI still fundamentally differs from true “drug use.”

This article “Swedish Creator Launches AI Drug Market PHARMAICY*: Requires Paid ChatGPT for Full Effect” first appeared on ABMedia.